MX9702666A - Nuevos peptidos con efectos inmunoreguladores. - Google Patents

Nuevos peptidos con efectos inmunoreguladores.

Info

Publication number
MX9702666A
MX9702666A MX9702666A MX9702666A MX9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A MX 9702666 A MX9702666 A MX 9702666A
Authority
MX
Mexico
Prior art keywords
new peptides
immunomodulatory effects
new
peptides
immunomodulatory
Prior art date
Application number
MX9702666A
Other languages
English (en)
Other versions
MXPA97002666A (es
Inventor
Hakan Bergstrand
Tomas Eriksson
Kostas Karabelas
Magnus Lindvall
Bengt Sarnstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MXPA97002666A publication Critical patent/MXPA97002666A/es
Publication of MX9702666A publication Critical patent/MX9702666A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nuevos péptidos de acuerdo con la formula (I), A-X-Y-Cys-Z-B, un proceso para la preparacion y su uso en la fabricacion de preparaciones farmacéuticas. Los péptidos nuevos son excelentes como inmunoregulares.
MX9702666A 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores. MX9702666A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
SE9403526.8 1994-10-14
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (2)

Publication Number Publication Date
MXPA97002666A MXPA97002666A (es) 1997-06-01
MX9702666A true MX9702666A (es) 1997-06-28

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702666A MX9702666A (es) 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores.

Country Status (20)

Country Link
US (2) US6103697A (es)
EP (1) EP0783519A1 (es)
JP (1) JPH10507448A (es)
AU (1) AU705364B2 (es)
BR (1) BR9509345A (es)
CA (1) CA2201479A1 (es)
CZ (1) CZ111997A3 (es)
EE (1) EE9700087A (es)
FI (1) FI971499A (es)
HU (1) HUT77118A (es)
IL (1) IL115509A0 (es)
IS (1) IS4459A (es)
MX (1) MX9702666A (es)
NO (1) NO971625L (es)
PL (1) PL319631A1 (es)
SE (1) SE9403526D0 (es)
SK (1) SK46797A3 (es)
TR (1) TR199501255A2 (es)
WO (1) WO1996011943A1 (es)
ZA (1) ZA958140B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
EP1083872A1 (en) * 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
AP2695A (en) 2005-04-25 2013-07-16 Cadila Pharmaceuticals Ltd Vaccine adjuvants
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
AU1366088A (en) 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) * 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するdnaおよび該アレルゲンの製造方法
KR100274321B1 (ko) 1990-09-11 2000-12-15 스미드 이. 그레이엄 데르마토파고이디즈(집 먼지 진드기)의 알레르기 항원의 클로닝 및 서열결정
AU2296792A (en) * 1991-06-28 1993-01-25 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
HU220462B1 (hu) 1991-10-16 2002-02-28 Immulogic Pharmaceutical Corp. A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンDer f II中のペプチド
JP3908271B2 (ja) 1993-03-05 2007-04-25 エピミューン,インコーポレイティド Hla−a2.1結合ペプチドおよびそれらの使用
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのb細胞エピトープ
AP690A (en) 1994-07-05 1998-10-16 Steeno Res Group A/S Immunomodulators based on a polypeptide other than human interleukin 10.
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
EE9700087A (et) 1997-10-15
SK46797A3 (en) 1997-09-10
CA2201479A1 (en) 1996-04-25
ZA958140B (en) 1997-06-27
SE9403526D0 (sv) 1994-10-14
JPH10507448A (ja) 1998-07-21
AU705364B2 (en) 1999-05-20
EP0783519A1 (en) 1997-07-16
IS4459A (is) 1997-04-08
HUT77118A (hu) 1998-03-02
NO971625L (no) 1997-05-30
CZ111997A3 (en) 1997-12-17
TR199501255A2 (tr) 1996-06-21
PL319631A1 (en) 1997-08-18
FI971499A0 (fi) 1997-04-10
AU3713395A (en) 1996-05-06
US6228374B1 (en) 2001-05-08
FI971499A (fi) 1997-06-10
NO971625D0 (no) 1997-04-09
IL115509A0 (en) 1996-05-14
BR9509345A (pt) 1997-11-25
US6103697A (en) 2000-08-15
WO1996011943A1 (en) 1996-04-25

Similar Documents

Publication Publication Date Title
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
MX9700885A (es) Nuevas heteroariloxazolidinonas.
DE69726714D1 (en) 9-oximsilyl erythromycin a derivate
CA2029678A1 (en) Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14
ZA9710796B (en) Oxyiminopregnanecarbolactones.
MY109143A (en) Sulfonamido-and sulfonamidocarbonylpyridine 2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
DE69826520D1 (en) 6-o-alkylerythromycinoxim b
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
MY115211A (en) Novel amino acid derivatives, their preparation and use
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
MX9803672A (es) Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos.
CA2028629A1 (en) Antiandrogenically-effective pharmaceutical compositions
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
CA2111083A1 (en) Novel peptides, their preparation and use
MX9603092A (es) Nuevos compuestos con efecto analgesico y anestesico local.
IL74138A (en) 4,6,6a,7,8,12b-hexahydro-indolo(4,3-ab)phenanthridines,their production and pharmaceutical compositions containing them
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
AU587680B2 (en) 2-benzimidazolylalkylthio (or-sulfinyl or -sulfonyl) derivatives, their preparations and their application as medicinal products